Neuberger Berman Group »

ADC Therapeutics SA shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $22k 21k 1.07

More positions owned by Neuberger Berman Group

Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Microsoft Corp Common (MSFT)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
Ishares Core S&p 500 Etf Etf (IVV)
Broadcom Common (AVGO)
Asml Holding Adr Representing Nv Common (ASML)
Meta Platforms Inc Class A A Common (META)
Home Depot Common (HD)
Nextera Energy Common (NEE)
Analog Devices Common (ADI)

View all positions for Neuberger Berman Group

Top funds holding ADC Therapeutics SA

Nantahala Capital Management
Redmile Group
TCG Crossover Management
Prosight Management
BlackRock
Morgan Stanley
Point72 Asset Management
Millennium Management
Citadel Advisors
Goldman Sachs Group
State Street Corporation
Geode Capital Management
Bank of America Corporation
Vanguard Portfolio Management
Two Sigma Investments

View all funds holding ADC Therapeutics SA